ctrlflw signal capture
TD2

TD2 sponsor universe

For TD2: every industry sponsor of a Phase 1 or Phase 2 oncology study on ClinicalTrials.gov whose record was first posted since January 2025, changed since April 2026, or is not yet recruiting, read on 1 Oct 2026 and joined to SEC Form D raises filed in the last twelve months. 1210 sponsors, grouped by how open the CRO decision looks from the public record, with nothing screened out for size, modality, or geography. The Accounts tab carries the eight worked in full; this tab is the whole field, so the targeting conversation can start anywhere.

Download the universe as a spreadsheet

Funded, no trial record yet 5

An oncology sponsor that closed a raise inside the last twelve months and has no industry Phase 1/2 record on ClinicalTrials.gov yet. The earliest moment a CRO can be in the room: six to twelve months before the bid list exists.

Window open now 260

A Phase 1 or 2 oncology record that reads Not yet recruiting today, whatever its posting date, or one first posted inside the last 120 days, with no CRO visible on the record. The CRO decision for this study, or for the expansion that follows it, is the live question.

Raised in the last 12 months, trial running 54

A SEC Form D raise filed inside the last twelve months at a sponsor whose record is already recruiting. The money funds the next cohort or the next program; the current CRO is not automatically the next.

Posted in the last nine months 84

First posted between four and nine months ago. The start-up decision is usually made; the expansion cohorts and the second study are not.

Running programs, next-award watch 432

Programs that were running before this screen. Kept so the next award at each sponsor is visible.

CRO on the record 43

A CRO is on the record, as the central contact's email domain or as a listed collaborator. Taken for this study. The door reopens on a hold, a termination, or an expansion, and the next asset is a fresh decision.

Large or prolific sponsors 327

Top-tier pharma or sponsors with twenty-five or more industry oncology records. Shown so nothing is hidden; not where a boutique CRO wins first.

Already on a TD2 record 5

Sponsors where TD2 already appears on a ClinicalTrials.gov record since 2017 as collaborator, contact or study official. Shown so the field is complete; these are TD2's own relationships, not targets.

These groupings rank research priority from public records read on 1 Oct 2026. They do not prove purchase intent, budget, or an open RFP. A record's central contact is the strongest public hint of who runs the study; it is a hint, not a vendor list. Sponsor names are as filed on ClinicalTrials.gov and the SEC.